Commercialization: Page 67

PharmaVoice Team/PharmaVoice

SFE With a New Business Model

There’s been much discussion over the past few years about the industry moving to a more consumer-centric sales model, and the time has come for a little less conversation and a little more action. The myriad challenges facing the industry and the increased adoption of technology by physicians ha...
By Robin Robinson • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Achieving Global Launch Excellence

The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incent...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Millennials: Problems or Prodigies?

Our experts say, however, this is a generation worth catering to, because if they are happy, they will most certainly succeed. Getting all four generations to work together effectively is challenging because the generations have difficulty relating to one another as they interact in the workplace...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Talent Pool

Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President Achillion Pharmaceuticals, which is focused on the discovery and development of small-molecule drugs to combat challenging infectious diseases, has promoted Chief Scientific Officer Milind Deshpande, Ph....
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

Social Media

CMP.LY to Address FDA/FTC Requirements Proponents of using the Internet for dispersing information and marketing efforts in the life-sciences field soon will have some alternative solutions that will allow the industry to continue its cautious move toward social media. One of those solutions was ...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

PharmaTrax

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: A Consistent Life-Cycle Management Strategy Can Counter Market Threats Innovation Remains Key to Drug Approval Strategy Sidebars: First-Cycle Approval Rates for Original NDAs (FY2003-FY2009) LCM Strategy Targeting Can M...
By PharmaVoice Team • Dec. 27, 2010
PharmaVoice Team/PharmaVoice

The Reps of Tomorrow

Given the environmental and sales target changes, the sales model must change to a concierge model, our experts say. This requires a very different approach and even a different type of salesperson. “Pharma companies can learn much from management consulting and service-selling skills," says Dave...
By Robin Robinson • Nov. 12, 2010
PharmaVoice Team/PharmaVoice

Digital Sales Tools Open Physician Doors

Digital media touch all facets of the relationship between pharmaceutical companies and prescribers. The reliance on building and sustaining the customer relationship through face-to-face interactions is changing dramatically. The increase in multichannel communications with customers and in part...
By Robin Robinson • Nov. 12, 2010
PharmaVoice Team/PharmaVoice

Unbranded Strategies Move From the Back Seat to the Driver's Position

In the future, the use and the value of unbranded promotion and messaging will continue to grow. Leigh Householder GSW Worldwide “The second biggest metric in pharma —behind sales — is sustained behavioral change, which means inspiring people to adopt healthier behaviors and adhere to treatment....
By Robin Robinson • Nov. 12, 2010
PharmaVoice Team/PharmaVoice

Showcases

Boomerang Pharmaceutical Communications 112 Main Rd., Bldg. 2 Ste. 6 Montville, NJ 07045 Phone: 973-265-8319 Fax: 973-265-8499 www.boomerangpharma.com Playful Name, Serious Results. Boomerang Pharmaceutical Communications is a global creative and results-driven, interactive ad agency. We define, ...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

External Experts: Optimal Engagement Strategies in a Digital Age

Organizations within the healthcare industry often work with external experts on an array of initiatives. These experts collaborate in a variety of ways, including working as advisory board members, investigators, media spokespeople, and speakers. Once a genuine need for expert engagement has bee...
By Jon Hudson Vice President • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Are You Properly Equipped to Execute Risk-Based Site Monitoring?

As the life-science industry focuses on moving toward a risk-based site monitoring approach where partial source document verification (SDV) is employed, it is critical that the clinical organization have the right tools and processes in place to efficiently execute such a strategy. As is typical...
By Ashwin Mundra • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Measuring ROI in Digital and Social: Five Metrics That Matter Now

Every successful digital and social plan has three complementary parts: the strategy, the marketing plan, and the optimization commitment. Leigh Householder Digital Strategist very conversation about digital and social marketing should start with these six words: What do you want to accomplish? ...
By Leigh Householder • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Achieving Digital Marketing Success

VIEW on E-SOLUTIONS Reaching Your Target Audience R.J. Lewis, President & CEO Your target audience is on the Internet, using e-mail, and connected via mobile in greater numbers than ever before. Yet the pharmaceutical industry’s digital media expenditures still come nowhere close to correlati...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

View on E-Solutions: In the E-Driver's Seat

Information Transformation In its report, Shaping the Future of Pharmaceutical R&D: Executing to a Vision of High Performance, Accenture noted that the leading-edge R&D groups are abandoning existing organizational barriers in favor of a networked, virtual, and flexible approach to R&...
By Carolyn Gretton • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Healthcare Reform and Comparative Effectiveness

We all know that R&D focus, pharmaceutical promotion, pricing, and reimbursement are all, or will be, critically affected by the biggest U.S. healthcare reform to occur in 40 years. The impact is going to be disruptive, but overall, experts says it will be a positive gain for the pharmaceutic...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

The Sales Force of the Future

Of all the factors that will influence how sales reps perform their jobs tomorrow, experts outline training, specialty roles, and social media as the top three that will most influence the size, strategies, and success of sales forces in the future. Training is Crucial. As new skill sets become ...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

To Twitter and Beyond

For several years there has been much debate regarding whether pharma companies should even use social media as a means to communicate with its consumers. Our experts project that social media will move beyond Twiiter and support many functions within marketing strategies, thus securing a permane...
By Robin Robinson • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Marketing: What Was Old Is New Again

Patients, ROI, an evolving landscape, and so on have been on the minds of marketers for years; but today success will lie in new solutions and approaches to overcome these chronic issues through innovative technologies and adaptive strategies. Patients Take Center Stage Our experts tell us that t...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

A More Conservative Regulatory Landscape

In the last few years, the FDA has come under strong criticism for the rate of adverse events, high-profile drug recalls, and contamination of both food and drug products. Agency officials have made steps to address drug safety and provide a more open and transparent regulatory environment. For t...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

The Crystal Ball

Dr. John Arrowsmith Scientific Director Thomson Reuters, which delivers critical information to leading decision makers in the financial, legal, tax and accounting, healthcare, science, and media markets. For more information, visit lifesciencesconsulting.thomsonreuters.com. 1. Outsourcing. There...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Talent Pool

Biopharmaceutical POOL Michael BAILEY Dr. Donna RADZIK Aveo Pharmaceuticals Bolsters Leadership Aveo Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics, has appointed Michael Bailey chief commercial officer. Mr. Bailey joins Av...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

On the Calendar

November 18-19 2nd Annual VA * DoD * PHS Federal Pricing and Contracts for Bio/Pharmaceutical Companies Courtyard Philadelphia Downtown, Philadelphia PharmaVOICE subscribers receive $400 discount; register using keycode RGR396. Center for Business Intelligence, cbinet.com November 18-19 West Coa...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

What's New

Ireland-based Firecrest has opened a facility in Princeton, N.J., that implements the company’s site performance management systems to help U.S.-based companies solve the challenges faced during clinical trial management and site performance. Firecrest’s products help investigators run complex tr...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

PharmaTrax

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Market Education Should Start Early in Oncology Drug Development Sidebar: Developing Thought Leaders Sales Call Volume Posts Slight Decline in First Half of 2010 Sidebar: Sales Calls for Top Pharma Companies Companies ...
By PharmaVoice Team • Nov. 9, 2010